Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Villegas · SciRah

Researcher profile · Semantic Scholar

A. Villegas

Share profile

A. Villegas — researcher profile on SciRah

h-index: 15
Works: 34
Citations: 6,407

Most-cited papers

Durvalumab after Chemoradiotherapy in Stage III Non–Small‐Cell Lung Cancer
S. Antonia, A. Villegas, D. Daniel, D. Vicente +26 more
2017New England Journal of Medicine2,703 citations Open access
Semantic Scholar
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. Antonia, A. Villegas, D. Daniel, D. Vicente +29 more
2018New England Journal of Medicine2,405 citations Open access
Semantic Scholar
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC
J. Gray, A. Villegas, D. Daniel, D. Vicente +16 more
2019Journal of Thoracic Oncology380 citations Open access
Semantic Scholar
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers
S. Peters, R. Stahel, L. Bubendorf, P. Bonomi +13 more
2018Clinical Cancer Research213 citations
Semantic Scholar
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
L. Paz-Ares, A. Spira, D. Raben, D. Planchard +17 more
2020Annals of Oncology207 citations Open access
Semantic Scholar
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
R. Hui, M. Özgüroğlu, A. Villegas, D. Daniel +14 more
2019The Lancet Oncology135 citations Open access
Semantic Scholar
Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC).
M. Socinski, M. Özgüroğlu, A. Villegas, D. Daniel +10 more
2021Clinical Lung Cancer58 citations Open access
Semantic Scholar
Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC).
C. Faivre-Finn, D. Spigel, S. Senan, C. Langer +12 more
2020Lung Cancer49 citations Open access
Semantic Scholar
MA05.02 PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT
J. Vansteenkiste, J. Naidoo, C. Faivre-Finn, M. Ozguroglu +11 more
2018Journal of Thoracic Oncology36 citations Open access
Semantic Scholar
Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC.
C. Faivre-Finn, D. Spigel, S. Senan, C. Langer +13 more
2018Annals of Oncology34 citations Open access
Semantic Scholar
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC
J. Vansteenkiste, J. Naidoo, C. Faivre-Finn, M. Özgüroğlu +12 more
2024JTO Clinical and Research Reports31 citations Open access
Semantic Scholar
Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
S. Senan, M. Özgüroğlu, D. Daniel, A. Villegas +9 more
2022ESMO Open30 citations Open access
Semantic Scholar
Efficacy, safety, and biomarker results of trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-overexpressing locally advanced or metastatic non-small cell lung cancer (mNSCLC).
T. Stinchcombe, R. Stahel, L. Bubendorf, P. Bonomi +13 more
201729 citations
Semantic Scholar
Three-year overall survival update from the PACIFIC trial.
J. Gray, A. Villegas, D. Daniel, D. Vicente +16 more
2019Journal of Clinical Oncology22 citations
Semantic Scholar
Three-year overall survival update from the PACIFIC trial
Y.-L. Wu, J. Gray, A. Villegas, D. Daniel +16 more
2019Annals of Oncology16 citations Open access
Semantic Scholar
Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)
J. Vansteenkiste, J. Naidoo, C. Faivre-Finn, M. Ozguroglu +11 more
2019Annals of Oncology14 citations Open access
Semantic Scholar
Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy
Pragathi Balakrishna, A. Villegas
2017Case Reports in Oncological Medicine13 citations Open access
Semantic Scholar
Overall Survival with Durvalumab versus Placebo after Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC
S. Antonia, A. Villegas, D. Daniel, D. Vicente +28 more
2018Pneumologie12 citations Open access
Semantic Scholar
Urachal Adenocarcinoma: A Rare Primary Cancer Managed With FOLFOX Chemotherapy
Jay Patel, A. Villegas
2023Cureus9 citations Open access
Semantic Scholar
First subsequent treatment after discontinuation of durvalumab in unresectable, stage III NSCLC patients from PACIFIC.
D. Planchard, B. Cho, J. Gray, L. Paz-Ares +14 more
2019Journal of Clinical Oncology9 citations
Semantic Scholar
COVID-19: A Rare Cause of Hemolytic Uremic Syndrome
K. Boldig, Rishu Batra, A. Villegas
2022Cureus8 citations Open access
Semantic Scholar
LBA1_PRPACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC
L. Paz-Ares, A. Villegas, D. Daniel, D. Baz +16 more
20176 citations Open access
Semantic Scholar
PACIFIC: Overall Survival with Durvalumab versus Placebo after Chemoradiotherapy in Stage III NSCLC
D. Raben, C. Faivre-Finn, D. Spigel, D. Daniel +15 more
2018International Journal of Radiation Oncology, Biology, Physics3 citations
Semantic Scholar
P1.16-05 Effect of Induction Chemotherapy in the PACIFIC Study
D. Spigel, J. Vansteenkiste, M. Reck, H. Wakelee +11 more
2018Journal of Thoracic Oncology2 citations Open access
Semantic Scholar
P1.16-04 Outcomes of Patients <70 or ≥70 Years of Age in PACIFIC
M. Socinski, M. Ozguroglu, A. Villegas, D. Daniel +11 more
2018Journal of Thoracic Oncology2 citations Open access
Semantic Scholar
403OPACIFIC: A double-blind, placebo-controlled Phase III study of durvalumab as consolidation therapy after chemoradiation in patients with locally advanced, unresectable NSCLC
S. Murakami, M. Ozguroglu, A. Villegas, D. Daniel +16 more
20171 citations Open access
Semantic Scholar
P-49 Stereotactic body radiotherapy (SBRT) for liver metastasis. Institutional experience
M. Merino, D. Schutte, V. Gregorat, A. Villegas +5 more
2023Annals of Oncology0 citations Open access
Semantic Scholar
PO-1209 SBRT in Women Over 70 Years Old with Early Breast Cancer
P. E. Murina, D. Angel, O. Muriano, A. Giraudo +3 more
2022Radiotherapy and Oncology0 citations
Semantic Scholar
Escalación de dosis de radioterapia con intensidad modulada y boost simultáneo integrado, asociada a capecitabine concurrente para cáncer de recto localmente avanzado
María Verónica Vera Merino, Daniela Angel Schütte, M. Almada, D. Venencia +10 more
2022Oncología Clínica0 citations Open access
Semantic Scholar
Abstract CT213: Impact of smoking on outcomes with durvalumab following chemoradiotherapy in unresectable Stage III NSCLC (PACIFIC)
D. Planchard, M. Özgüroğlu, D. Daniel, A. Villegas +10 more
2020Tumor Biology0 citations
Semantic Scholar
Diseño de un plan de marketing para un comercio de indumentaria.
A. Villegas
20190 citations
Semantic Scholar
233O Time to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomes
R. Hui, M. Ozguroglu, A. Villegas, D. Daniel +6 more
20180 citations Open access
Semantic Scholar
P1.16-06 Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%
A. Spira, D. Planchard, B. Cho, M. Ozguroglu +11 more
2018Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non–Small Cell Lung Cancer
S. Antonia, A. Villegas, D. Daniel, D. Baz +16 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Daniel×24
Invite
D. Daniel — researcher profile on SciRah
R. Hui×24
Invite
R. Hui — researcher profile on SciRah
S. Murakami×19
Invite
S. Murakami — researcher profile on SciRah
P. Dennis×19
Invite
P. Dennis — researcher profile on SciRah

×18

Invite

D. Vicente — researcher profile on SciRah

L. Paz-Ares×16

Invite

L. Paz-Ares — researcher profile on SciRah

C. Wadsworth×16

Invite

C. Wadsworth — researcher profile on SciRah

Invite

S. Antonia — researcher profile on SciRah

C. Faivre-Finn×14

Invite

C. Faivre-Finn — researcher profile on SciRah

D. Planchard×13

Invite

D. Planchard — researcher profile on SciRah

M. Özgüroğlu×13

Invite

M. Özgüroğlu — researcher profile on SciRah

A. Chiappori×12

Invite

A. Chiappori — researcher profile on SciRah